-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The deadline for the news of medical network on March 24! A batch of pharmaceutical companies was notified
Two provinces successively issued notices
On March 23, the Shaanxi Provincial Public Resources Trading Center issued a notice on submitting the "Pharmaceutical Enterprise Price and Marketing Behavior Credit Commitment" as soon as possible.
According to the "Guiding Opinions of the National Medical Security Administration on Establishing a Medical Price and Recruitment Credit Evaluation System", the center organized platform-related pharmaceutical companies to submit the "Pharmaceutical Enterprise Price and Marketing Behavior Credit Commitment".
As of February 28, there are still 4,056 pharmaceutical companies failed to upload as required, including 623 pharmaceutical production companies, 438 pharmaceutical distribution companies, 666 consumables production companies, and 2,329 consumables distribution companies.
As of February 28, there are still 4,056 pharmaceutical companies failed to upload as required, including 623 pharmaceutical production companies, 438 pharmaceutical distribution companies, 666 consumables production companies, and 2,329 consumables distribution companies.
For companies that have not submitted a written commitment, they will no longer accept new bids or online applications from April 1st; starting from June 1st, for pharmaceutical companies and their products that have won bids or listed online, they are in On the premise of demand, cancel its connection to the network.
Coincidentally, yesterday (March 22), the Hunan Provincial Public Resources Trading Center also notified pharmaceutical companies on the status of uploading price and marketing credit commitments.
As of March 19, there are still 2,625 pharmaceutical companies that have failed to upload as required.
Among them, the number of pharmaceutical companies that have not submitted credit commitments is 709, and the number of delivery companies that have not submitted credit commitments is 1916.
As of March 19, there are still 2,625 pharmaceutical companies that have failed to upload as required.
Among them, the number of pharmaceutical companies that have not submitted credit commitments is 709, and the number of delivery companies that have not submitted credit commitments is 1916.
Similarly, for pharmaceutical companies that have not submitted credit commitments, they will no longer accept new bids or online applications from April 1st, and they will be granted with guaranteed supply for their products that have won bids or listed online from June 1st.
Withdraw the net.
Withdraw the net.
The total number of pharmaceutical companies notified within two days reached 6,681.
Many provinces have issued notices one after another
In September 2020, the National Medical Insurance Administration issued the "Guiding Opinions of the National Medical Security Administration on Establishing a Medical Price and Recruitment Credit Evaluation System.
" The document pointed out that in order to promote the improvement of the market-oriented pharmaceutical price formation mechanism, it is necessary to establish a list of credit evaluation catalogs, a pharmaceutical company’s active commitment mechanism, a mechanism for reporting untrustworthy information, a mechanism for pharmaceutical companies’ credit rating, a mechanism for grading untrustworthy behaviors, and a mechanism for pharmaceutical companies.
In six aspects of the credit repair mechanism, establish a credit evaluation system for medicine prices and recruitment and procurement.
" The document pointed out that in order to promote the improvement of the market-oriented pharmaceutical price formation mechanism, it is necessary to establish a list of credit evaluation catalogs, a pharmaceutical company’s active commitment mechanism, a mechanism for reporting untrustworthy information, a mechanism for pharmaceutical companies’ credit rating, a mechanism for grading untrustworthy behaviors, and a mechanism for pharmaceutical companies.
In six aspects of the credit repair mechanism, establish a credit evaluation system for medicine prices and recruitment and procurement.
In December 2020, the National Medical Insurance Administration issued the “Notice on Accelerating the Implementation of the Medical Price and Recruitment Credit Evaluation System”, requiring that by the end of February 2021, the proportion of written commitments submitted by bidding and online companies should reach more than 80%.
By the end of the month, it will reach more than 95%.
If the submission is not timely, the provincial centralized procurement agency shall promptly remind the time limit requirements, inform the relevant impact, and make detailed records as the basis for subsequent processing.
By the end of the month, it will reach more than 95%.
If the submission is not timely, the provincial centralized procurement agency shall promptly remind the time limit requirements, inform the relevant impact, and make detailed records as the basis for subsequent processing.
According to incomplete statistics, many provinces have issued relevant notices.
On January 7, 2021, the Shanxi Provincial Medical Insurance Bureau formulated and issued the "Implementation Opinions on Establishing a Medical Price and Recruitment Credit Evaluation System" to promote the establishment of a medical price and recruitment credit evaluation system.
On December 30, 2020, Shanghai issued the "Notice on the Establishment and Implementation of the Medical Price and Recruitment Credit Evaluation System in this Municipality.
" On the same day, the Guangdong Provincial Medical Insurance Bureau issued the "Notice on Establishing a Medical Price and Recruitment Credit Evaluation System.
" In addition, Yunnan, Fujian, Anhui, Guizhou and other places have also issued relevant notices.
On December 30, 2020, Shanghai issued the "Notice on the Establishment and Implementation of the Medical Price and Recruitment Credit Evaluation System in this Municipality.
" On the same day, the Guangdong Provincial Medical Insurance Bureau issued the "Notice on Establishing a Medical Price and Recruitment Credit Evaluation System.
" In addition, Yunnan, Fujian, Anhui, Guizhou and other places have also issued relevant notices.
It is worth noting that Guangdong Province is led by the provincial platform, and together with the procurement platforms of Guangzhou and Shenzhen, a unified untrustworthy information database has been established across the province, and all procurement platforms share credit rating information.
The requirement of Anhui Province is to complete the submission of the electronic commitment letter before January 29, 2021.
Taking into account the normalization of epidemic prevention and control, after the electronic commitment letter is submitted, there is no need to submit the paper commitment letter.
Taking into account the normalization of epidemic prevention and control, after the electronic commitment letter is submitted, there is no need to submit the paper commitment letter.
Guizhou Province’s requirements for submission time are classified.
Pharmaceutical companies related to pharmaceutical production should complete the uploading of the commitment letter before January 31, 2021, and pharmaceutical companies related to the production of medical consumables should complete the uploading of the commitment letter before February 28, 2021.
.
In addition, before the last working day of the first month of each quarter, the Provincial Trading Center will announce the latest credit rating results on the Guizhou Provincial Pharmaceutical Centralized Procurement Platform, and take corresponding measures simultaneously.
Pharmaceutical companies related to pharmaceutical production should complete the uploading of the commitment letter before January 31, 2021, and pharmaceutical companies related to the production of medical consumables should complete the uploading of the commitment letter before February 28, 2021.
.
In addition, before the last working day of the first month of each quarter, the Provincial Trading Center will announce the latest credit rating results on the Guizhou Provincial Pharmaceutical Centralized Procurement Platform, and take corresponding measures simultaneously.
Remediation of medical rebates
The "Guiding Opinions of the National Medical Security Administration on Establishing a Credit Evaluation System for Pharmaceutical Prices and Recruitment and Procurement" was issued in response to outstanding issues such as rebates and monopoly price increases in the pharmaceutical field.
According to a reporter’s question by the Price Recruitment Department of the National Medical Insurance Administration, taking the issue of drug rebates as an example, according to the statistics of publicly available court judgments, from 2016 to 2019, more than half of the 100 compulsory drug companies in the country were found to have given or The behavior of indirectly giving kickbacks, among which the most frequent companies involved more than 20 cases in three years, and the kickback amount in a single case exceeded 20 million yuan.
The average sales expense ratio of listed pharmaceutical companies exceeds 30%.
The average sales expense ratio of listed pharmaceutical companies exceeds 30%.
The document pointed out that it is necessary to establish a credit evaluation mechanism, give play to the guiding and standardizing role of the centralized drug procurement market, and take appropriate measures against untrustworthy enterprises.
Encourage enterprises to conduct market transactions in accordance with the principles of "fairness, reasonableness, honesty and credibility, and conformity with quality and price" to maintain market order.
Encourage enterprises to conduct market transactions in accordance with the principles of "fairness, reasonableness, honesty and credibility, and conformity with quality and price" to maintain market order.
In the past, some pharmaceutical companies were often insensitive to fines in such cases.
However, in the context of national procurement and provincial procurement, the price of medicines and the credit evaluation system for procurement and procurement will make untrustworthy companies lose the opportunity to enter the centralized procurement market, which has a powerful deterrent effect.
.
However, in the context of national procurement and provincial procurement, the price of medicines and the credit evaluation system for procurement and procurement will make untrustworthy companies lose the opportunity to enter the centralized procurement market, which has a powerful deterrent effect.
.
On February 3, a notice was posted on the official website of Hunan Pharmaceutical Centralized Procurement, announcing the results of the treatment of vitamin B6 products from a pharmaceutical company.
The drug company was deemed to have "distrustworthy behavior" and was cancelled the qualification of vitamin B6 injection (2m: 0.
1g) to be online in Hunan Province for one year.
At the same time, the dishonesty behavior was recorded.
The drug company was deemed to have "distrustworthy behavior" and was cancelled the qualification of vitamin B6 injection (2m: 0.
1g) to be online in Hunan Province for one year.
At the same time, the dishonesty behavior was recorded.
According to the reporter's question, the National Medical Security Administration will continue to make efforts to rectify the problem of drug rebates from three aspects: deepening the reform of the centralized procurement system, improving the total budget management and quantitative assessment of the medical insurance fund, and promoting the reform of medical service prices .
The state has become more and more strict in the management of drug rebates, and the management and operation of enterprises must also become more and more standardized, and the market will develop in a healthy way .
Companies that have ideas for centralized pharmnet.
com.
cn/news/yyzb/" target="_blank">procurement and drug listings need to pay attention to the requirements of different provinces and submit letters of commitment to keep promises in a timely manner.
In addition, after submission, you should always check yourself for any untrustworthy behavior and submit the information immediately.
Otherwise, you will face severe penalties for being cancelled.
Companies that have ideas for centralized pharmnet.
com.
cn/news/yyzb/" target="_blank">procurement and drug listings need to pay attention to the requirements of different provinces and submit letters of commitment to keep promises in a timely manner.
In addition, after submission, you should always check yourself for any untrustworthy behavior and submit the information immediately.
Otherwise, you will face severe penalties for being cancelled.
The deadline for the news of medical network on March 24! A batch of pharmaceutical companies was notified
Two provinces successively issued notices
On March 23, the Shaanxi Provincial Public Resources Trading Center issued a notice on submitting the "Pharmaceutical Enterprise Price and Marketing Behavior Credit Commitment" as soon as possible.
According to the "Guiding Opinions of the National Medical Security Administration on Establishing a Medical Price and Recruitment Credit Evaluation System", the center organized platform-related pharmaceutical companies to submit the "Pharmaceutical Enterprise Price and Marketing Behavior Credit Commitment".
As of February 28, there are still 4,056 pharmaceutical companies failed to upload as required, including 623 pharmaceutical production companies, 438 pharmaceutical distribution companies, 666 consumables production companies, and 2,329 consumables distribution companies.
As of February 28, there are still 4,056 pharmaceutical companies failed to upload as required, including 623 pharmaceutical production companies, 438 pharmaceutical distribution companies, 666 consumables production companies, and 2,329 consumables distribution companies.
For companies that have not submitted a written commitment, they will no longer accept new bids or online applications from April 1st; starting from June 1st, for pharmaceutical companies and their products that have won bids or listed online, they are in On the premise of demand, cancel its connection to the network.
Coincidentally, yesterday (March 22), the Hunan Provincial Public Resources Trading Center also notified pharmaceutical companies on the status of uploading price and marketing credit commitments.
As of March 19, there are still 2,625 pharmaceutical companies that have failed to upload as required.
Among them, the number of pharmaceutical companies that have not submitted credit commitments is 709, and the number of delivery companies that have not submitted credit commitments is 1916.
As of March 19, there are still 2,625 pharmaceutical companies that have failed to upload as required.
Among them, the number of pharmaceutical companies that have not submitted credit commitments is 709, and the number of delivery companies that have not submitted credit commitments is 1916.
Similarly, for pharmaceutical companies that have not submitted credit commitments, they will no longer accept new bids or online applications from April 1st, and they will be granted with guaranteed supply for their products that have won bids or listed online from June 1st.
Withdraw the net.
Withdraw the net.
The total number of pharmaceutical companies notified within two days reached 6,681.
Many provinces have issued notices one after another
In September 2020, the National Medical Insurance Administration issued the "Guiding Opinions of the National Medical Security Administration on Establishing a Medical Price and Recruitment Credit Evaluation System.
" The document pointed out that in order to promote the improvement of the market-oriented pharmaceutical price formation mechanism, it is necessary to establish a list of credit evaluation catalogs, a pharmaceutical company’s active commitment mechanism, a mechanism for reporting untrustworthy information, a mechanism for pharmaceutical companies’ credit rating, a mechanism for grading untrustworthy behaviors, and a mechanism for pharmaceutical companies.
In six aspects of the credit repair mechanism, establish a credit evaluation system for medicine prices and recruitment and procurement.
" The document pointed out that in order to promote the improvement of the market-oriented pharmaceutical price formation mechanism, it is necessary to establish a list of credit evaluation catalogs, a pharmaceutical company’s active commitment mechanism, a mechanism for reporting untrustworthy information, a mechanism for pharmaceutical companies’ credit rating, a mechanism for grading untrustworthy behaviors, and a mechanism for pharmaceutical companies.
In six aspects of the credit repair mechanism, establish a credit evaluation system for medicine prices and recruitment and procurement.
In December 2020, the National Medical Insurance Administration issued the “Notice on Accelerating the Implementation of the Medical Price and Recruitment Credit Evaluation System”, requiring that by the end of February 2021, the proportion of written commitments submitted by bidding and online companies should reach more than 80%.
By the end of the month, it will reach more than 95%.
If the submission is not timely, the provincial centralized procurement agency shall promptly remind the time limit requirements, inform the relevant impact, and make detailed records as the basis for subsequent processing.
By the end of the month, it will reach more than 95%.
If the submission is not timely, the provincial centralized procurement agency shall promptly remind the time limit requirements, inform the relevant impact, and make detailed records as the basis for subsequent processing.
According to incomplete statistics, many provinces have issued relevant notices.
On January 7, 2021, the Shanxi Provincial Medical Insurance Bureau formulated and issued the "Implementation Opinions on Establishing a Medical Price and Recruitment Credit Evaluation System" to promote the establishment of a medical price and recruitment credit evaluation system.
On December 30, 2020, Shanghai issued the "Notice on the Establishment and Implementation of the Medical Price and Recruitment Credit Evaluation System in this Municipality.
" On the same day, the Guangdong Provincial Medical Insurance Bureau issued the "Notice on Establishing a Medical Price and Recruitment Credit Evaluation System.
" In addition, Yunnan, Fujian, Anhui, Guizhou and other places have also issued relevant notices.
On December 30, 2020, Shanghai issued the "Notice on the Establishment and Implementation of the Medical Price and Recruitment Credit Evaluation System in this Municipality.
" On the same day, the Guangdong Provincial Medical Insurance Bureau issued the "Notice on Establishing a Medical Price and Recruitment Credit Evaluation System.
" In addition, Yunnan, Fujian, Anhui, Guizhou and other places have also issued relevant notices.
It is worth noting that Guangdong Province is led by the provincial platform, and together with the procurement platforms of Guangzhou and Shenzhen, a unified untrustworthy information database has been established across the province, and all procurement platforms share credit rating information.
The requirement of Anhui Province is to complete the submission of the electronic commitment letter before January 29, 2021.
Taking into account the normalization of epidemic prevention and control, after the electronic commitment letter is submitted, there is no need to submit the paper commitment letter.
Taking into account the normalization of epidemic prevention and control, after the electronic commitment letter is submitted, there is no need to submit the paper commitment letter.
Guizhou Province’s requirements for submission time are classified.
Pharmaceutical companies related to pharmaceutical production should complete the uploading of the commitment letter before January 31, 2021, and pharmaceutical companies related to the production of medical consumables should complete the uploading of the commitment letter before February 28, 2021.
.
In addition, before the last working day of the first month of each quarter, the Provincial Trading Center will announce the latest credit rating results on the Guizhou Provincial Pharmaceutical Centralized Procurement Platform, and take corresponding measures simultaneously.
Pharmaceutical companies related to pharmaceutical production should complete the uploading of the commitment letter before January 31, 2021, and pharmaceutical companies related to the production of medical consumables should complete the uploading of the commitment letter before February 28, 2021.
.
In addition, before the last working day of the first month of each quarter, the Provincial Trading Center will announce the latest credit rating results on the Guizhou Provincial Pharmaceutical Centralized Procurement Platform, and take corresponding measures simultaneously.
Remediation of medical rebates
The "Guiding Opinions of the National Medical Security Administration on Establishing a Credit Evaluation System for Pharmaceutical Prices and Recruitment and Procurement" was issued in response to outstanding issues such as rebates and monopoly price increases in the pharmaceutical field.
According to a reporter’s question by the Price Recruitment Department of the National Medical Insurance Administration, taking the issue of drug rebates as an example, according to the statistics of publicly available court judgments, from 2016 to 2019, more than half of the 100 compulsory drug companies in the country were found to have given or The behavior of indirectly giving kickbacks, among which the most frequent companies involved more than 20 cases in three years, and the kickback amount in a single case exceeded 20 million yuan.
The average sales expense ratio of listed pharmaceutical companies exceeds 30%.
The average sales expense ratio of listed pharmaceutical companies exceeds 30%.
The document pointed out that it is necessary to establish a credit evaluation mechanism, give play to the guiding and standardizing role of the centralized drug procurement market, and take appropriate measures against untrustworthy enterprises.
Encourage enterprises to conduct market transactions in accordance with the principles of "fairness, reasonableness, honesty and credibility, and conformity with quality and price" to maintain market order.
Encourage enterprises to conduct market transactions in accordance with the principles of "fairness, reasonableness, honesty and credibility, and conformity with quality and price" to maintain market order.
In the past, some pharmaceutical companies were often insensitive to fines in such cases.
However, in the context of national procurement and provincial procurement, the price of medicines and the credit evaluation system for procurement and procurement will make untrustworthy companies lose the opportunity to enter the centralized procurement market, which has a powerful deterrent effect.
.
However, in the context of national procurement and provincial procurement, the price of medicines and the credit evaluation system for procurement and procurement will make untrustworthy companies lose the opportunity to enter the centralized procurement market, which has a powerful deterrent effect.
.
On February 3, a notice was posted on the official website of Hunan Pharmaceutical Centralized Procurement, announcing the results of the treatment of vitamin B6 products from a pharmaceutical company.
The drug company was deemed to have "distrustworthy behavior" and was cancelled the qualification of vitamin B6 injection (2m: 0.
1g) to be online in Hunan Province for one year.
At the same time, the dishonesty behavior was recorded.
The drug company was deemed to have "distrustworthy behavior" and was cancelled the qualification of vitamin B6 injection (2m: 0.
1g) to be online in Hunan Province for one year.
At the same time, the dishonesty behavior was recorded.
According to the reporter's question, the National Medical Security Administration will continue to make efforts to rectify the problem of drug rebates from three aspects: deepening the reform of the centralized procurement system, improving the total budget management and quantitative assessment of the medical insurance fund, and promoting the reform of medical service prices .
The state has become more and more strict in the management of drug rebates, and the management and operation of enterprises must also become more and more standardized, and the market will develop in a healthy way .
Companies that have ideas for centralized pharmnet.
com.
cn/news/yyzb/" target="_blank">procurement and drug listings need to pay attention to the requirements of different provinces and submit letters of commitment to keep promises in a timely manner.
In addition, after submission, you should always check yourself for any untrustworthy behavior and submit the information immediately.
Otherwise, you will face severe penalties for being cancelled.
Companies that have ideas for centralized pharmnet.
com.
cn/news/yyzb/" target="_blank">procurement and drug listings need to pay attention to the requirements of different provinces and submit letters of commitment to keep promises in a timely manner.
In addition, after submission, you should always check yourself for any untrustworthy behavior and submit the information immediately.
Otherwise, you will face severe penalties for being cancelled.
The deadline for the news of medical network on March 24! A batch of pharmaceutical companies was notified
Two provinces successively issued notices
Two provinces successively issued notices On March 23, the Shaanxi Provincial Public Resources Trading Center issued a notice on submitting the "Pharmaceutical Enterprise Price and Marketing Behavior Credit Commitment" as soon as possible.
According to the "Guiding Opinions of the National Medical Security Administration on Establishing a Medical Price and Recruitment Credit Evaluation System", the center organized platform-related pharmaceutical companies to submit the "Pharmaceutical Enterprise Price and Marketing Behavior Credit Commitment".
As of February 28, there are still 4,056 pharmaceutical companies failed to upload as required, including 623 pharmaceutical production companies, 438 pharmaceutical distribution companies, 666 consumables production companies, and 2,329 consumables distribution companies.
As of February 28, there are still 4,056 pharmaceutical companies failed to upload as required, including 623 pharmaceutical production companies, 438 pharmaceutical distribution companies, 666 consumables production companies, and 2,329 consumables distribution companies.
For companies that have not submitted a written commitment, they will no longer accept new bids or online applications from April 1st; starting from June 1st, for pharmaceutical companies and their products that have won bids or listed online, they are in On the premise of demand, cancel its connection to the network.
Coincidentally, yesterday (March 22), the Hunan Provincial Public Resources Trading Center also notified pharmaceutical companies on the status of uploading price and marketing credit commitments.
As of March 19, there are still 2,625 pharmaceutical companies that have failed to upload as required.
Among them, the number of pharmaceutical companies that have not submitted credit commitments is 709, and the number of delivery companies that have not submitted credit commitments is 1916.
As of March 19, there are still 2,625 pharmaceutical companies that have failed to upload as required.
Among them, the number of pharmaceutical companies that have not submitted credit commitments is 709, and the number of delivery companies that have not submitted credit commitments is 1916.
Similarly, for pharmaceutical companies that have not submitted credit commitments, they will no longer accept new bids or online applications from April 1st, and they will be granted with guaranteed supply for their products that have won bids or listed online from June 1st.
Withdraw the net.
Withdraw the net.
The total number of pharmaceutical companies notified within two days reached 6,681.
Many provinces have issued notices one after another
Many provinces have issued notices one after another In September 2020, the National Medical Insurance Administration issued the "Guiding Opinions of the National Medical Security Administration on Establishing a Medical Price and Recruitment Credit Evaluation System.
" The document pointed out that in order to promote the improvement of the market-oriented pharmaceutical price formation mechanism, it is necessary to establish a list of credit evaluation catalogs, a pharmaceutical company’s active commitment mechanism, a mechanism for reporting untrustworthy information, a mechanism for pharmaceutical companies’ credit rating, a mechanism for grading untrustworthy behaviors, and a mechanism for pharmaceutical companies.
In six aspects of the credit repair mechanism, establish a credit evaluation system for medicine prices and recruitment and procurement.
" The document pointed out that in order to promote the improvement of the market-oriented pharmaceutical price formation mechanism, it is necessary to establish a list of credit evaluation catalogs, a pharmaceutical company’s active commitment mechanism, a mechanism for reporting untrustworthy information, a mechanism for pharmaceutical companies’ credit rating, a mechanism for grading untrustworthy behaviors, and a mechanism for pharmaceutical companies.
In six aspects of the credit repair mechanism, establish a credit evaluation system for medicine prices and recruitment and procurement.
In December 2020, the National Medical Insurance Administration issued the “Notice on Accelerating the Implementation of the Medical Price and Recruitment Credit Evaluation System”, requiring that by the end of February 2021, the proportion of written commitments submitted by bidding and online companies should reach more than 80%.
By the end of the month, it will reach more than 95%.
If the submission is not timely, the provincial centralized procurement agency shall promptly remind the time limit requirements, inform the relevant impact, and make detailed records as the basis for subsequent processing.
By the end of the month, it will reach more than 95%.
If the submission is not timely, the provincial centralized procurement agency shall promptly remind the time limit requirements, inform the relevant impact, and make detailed records as the basis for subsequent processing.
According to incomplete statistics, many provinces have issued relevant notices.
On January 7, 2021, the Shanxi Provincial Medical Insurance Bureau formulated and issued the "Implementation Opinions on Establishing a Medical Price and Recruitment Credit Evaluation System" to promote the establishment of a medical price and recruitment credit evaluation system.
On December 30, 2020, Shanghai issued the "Notice on the Establishment and Implementation of the Medical Price and Recruitment Credit Evaluation System in this Municipality.
" On the same day, the Guangdong Provincial Medical Insurance Bureau issued the "Notice on Establishing a Medical Price and Recruitment Credit Evaluation System.
" In addition, Yunnan, Fujian, Anhui, Guizhou and other places have also issued relevant notices.
On December 30, 2020, Shanghai issued the "Notice on the Establishment and Implementation of the Medical Price and Recruitment Credit Evaluation System in this Municipality.
" On the same day, the Guangdong Provincial Medical Insurance Bureau issued the "Notice on Establishing a Medical Price and Recruitment Credit Evaluation System.
" In addition, Yunnan, Fujian, Anhui, Guizhou and other places have also issued relevant notices.
It is worth noting that Guangdong Province is led by the provincial platform, and together with the procurement platforms of Guangzhou and Shenzhen, a unified untrustworthy information database has been established across the province, and all procurement platforms share credit rating information.
The requirement of Anhui Province is to complete the submission of the electronic commitment letter before January 29, 2021.
Taking into account the normalization of epidemic prevention and control, after the electronic commitment letter is submitted, there is no need to submit the paper commitment letter.
Taking into account the normalization of epidemic prevention and control, after the electronic commitment letter is submitted, there is no need to submit the paper commitment letter.
Guizhou Province’s requirements for submission time are classified.
Pharmaceutical companies related to pharmaceutical production should complete the uploading of the commitment letter before January 31, 2021, and pharmaceutical companies related to the production of medical consumables should complete the uploading of the commitment letter before February 28, 2021.
.
In addition, before the last working day of the first month of each quarter, the Provincial Trading Center will announce the latest credit rating results on the Guizhou Provincial Pharmaceutical Centralized Procurement Platform, and take corresponding measures simultaneously.
Pharmaceutical companies related to pharmaceutical production should complete the uploading of the commitment letter before January 31, 2021, and pharmaceutical companies related to the production of medical consumables should complete the uploading of the commitment letter before February 28, 2021.
.
In addition, before the last working day of the first month of each quarter, the Provincial Trading Center will announce the latest credit rating results on the Guizhou Provincial Pharmaceutical Centralized Procurement Platform, and take corresponding measures simultaneously.
Remediation of medical rebates
Remediation of medical rebates The "Guiding Opinions of the National Medical Security Administration on Establishing a Credit Evaluation System for Pharmaceutical Prices and Recruitment and Procurement" was issued in response to outstanding issues such as rebates and monopoly price increases in the pharmaceutical field.
According to a reporter’s question by the Price Recruitment Department of the National Medical Insurance Administration, taking the issue of drug rebates as an example, according to the statistics of publicly available court judgments, from 2016 to 2019, more than half of the 100 compulsory drug companies in the country were found to have given or The behavior of indirectly giving kickbacks, among which the most frequent companies involved more than 20 cases in three years, and the kickback amount in a single case exceeded 20 million yuan.
The average sales expense ratio of listed pharmaceutical companies exceeds 30%.
The average sales expense ratio of listed pharmaceutical companies exceeds 30%.
The document pointed out that it is necessary to establish a credit evaluation mechanism, give play to the guiding and standardizing role of the centralized drug procurement market, and take appropriate measures against untrustworthy enterprises.
Encourage enterprises to conduct market transactions in accordance with the principles of "fairness, reasonableness, honesty and credibility, and conformity with quality and price" to maintain market order.
Encourage enterprises to conduct market transactions in accordance with the principles of "fairness, reasonableness, honesty and credibility, and conformity with quality and price" to maintain market order.
In the past, some pharmaceutical companies were often insensitive to fines in such cases.
However, in the context of national procurement and provincial procurement, the price of medicines and the credit evaluation system for procurement and procurement will make untrustworthy companies lose the opportunity to enter the centralized procurement market, which has a powerful deterrent effect.
.
However, in the context of national procurement and provincial procurement, the price of medicines and the credit evaluation system for procurement and procurement will make untrustworthy companies lose the opportunity to enter the centralized procurement market, which has a powerful deterrent effect.
.
23，，B6。“”，B6（2m：0.
1g），，。
1g），，。
，、、。
，，。pharmnet.
com.
cn/news/yyzb/" target="_blank">、，，。，，。，。
pharmnet. com.
cn/news/yyzb/" target="_blank">、，，。，，。，。
com.
cn/news/yyzb/" target="_blank">pharmnet.
com.
cn/news/yyzb/" target="_blank">
